The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vials for COVID-19 Vaccine Market Research Report 2025
Synopsis
The global Vials for COVID-19 Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vials for COVID-19 Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vials for COVID-19 Vaccine.
Report Scope
The Vials for COVID-19 Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vials for COVID-19 Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vials for COVID-19 Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Corning
Schott AG
SiO2 Materials Science
SGD Pharma
Stevanato Group
DWK Life Sciences
Gerresheimer
Segment by Type
Middle-borate Borosilicate Glass
Low-borate Borosilicate Glass
Segment by Application
Vaccine Manufacturing
Vaccine Researching
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vials for COVID-19 Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vials for COVID-19 Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Vials for COVID-19 Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vials for COVID-19 Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vials for COVID-19 Vaccine.
Report Scope
The Vials for COVID-19 Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Million Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vials for COVID-19 Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vials for COVID-19 Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Corning
Schott AG
SiO2 Materials Science
SGD Pharma
Stevanato Group
DWK Life Sciences
Gerresheimer
Segment by Type
Middle-borate Borosilicate Glass
Low-borate Borosilicate Glass
Segment by Application
Vaccine Manufacturing
Vaccine Researching
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vials for COVID-19 Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vials for COVID-19 Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vials for COVID-19 Vaccine Market Overview
1.1 Product Overview and Scope of Vials for COVID-19 Vaccine
1.2 Vials for COVID-19 Vaccine Segment by Type
1.2.1 Global Vials for COVID-19 Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Middle-borate Borosilicate Glass
1.2.3 Low-borate Borosilicate Glass
1.3 Vials for COVID-19 Vaccine Segment by Application
1.3.1 Global Vials for COVID-19 Vaccine Market Value by Application: (2024-2030)
1.3.2 Vaccine Manufacturing
1.3.3 Vaccine Researching
1.4 Global Vials for COVID-19 Vaccine Market Size Estimates and Forecasts
1.4.1 Global Vials for COVID-19 Vaccine Revenue 2019-2030
1.4.2 Global Vials for COVID-19 Vaccine Sales 2019-2030
1.4.3 Global Vials for COVID-19 Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vials for COVID-19 Vaccine Market Competition by Manufacturers
2.1 Global Vials for COVID-19 Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vials for COVID-19 Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vials for COVID-19 Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Vials for COVID-19 Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vials for COVID-19 Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vials for COVID-19 Vaccine, Product Type & Application
2.7 Vials for COVID-19 Vaccine Market Competitive Situation and Trends
2.7.1 Vials for COVID-19 Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vials for COVID-19 Vaccine Players Market Share by Revenue
2.7.3 Global Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vials for COVID-19 Vaccine Retrospective Market Scenario by Region
3.1 Global Vials for COVID-19 Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vials for COVID-19 Vaccine Global Vials for COVID-19 Vaccine Sales by Region: 2019-2030
3.2.1 Global Vials for COVID-19 Vaccine Sales by Region: 2019-2024
3.2.2 Global Vials for COVID-19 Vaccine Sales by Region: 2025-2030
3.3 Global Vials for COVID-19 Vaccine Global Vials for COVID-19 Vaccine Revenue by Region: 2019-2030
3.3.1 Global Vials for COVID-19 Vaccine Revenue by Region: 2019-2024
3.3.2 Global Vials for COVID-19 Vaccine Revenue by Region: 2025-2030
3.4 North America Vials for COVID-19 Vaccine Market Facts & Figures by Country
3.4.1 North America Vials for COVID-19 Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vials for COVID-19 Vaccine Sales by Country (2019-2030)
3.4.3 North America Vials for COVID-19 Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vials for COVID-19 Vaccine Market Facts & Figures by Country
3.5.1 Europe Vials for COVID-19 Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vials for COVID-19 Vaccine Sales by Country (2019-2030)
3.5.3 Europe Vials for COVID-19 Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vials for COVID-19 Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Vials for COVID-19 Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vials for COVID-19 Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Vials for COVID-19 Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vials for COVID-19 Vaccine Market Facts & Figures by Country
3.7.1 Latin America Vials for COVID-19 Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vials for COVID-19 Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Vials for COVID-19 Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vials for COVID-19 Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Vials for COVID-19 Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vials for COVID-19 Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vials for COVID-19 Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vials for COVID-19 Vaccine Sales by Type (2019-2030)
4.1.1 Global Vials for COVID-19 Vaccine Sales by Type (2019-2024)
4.1.2 Global Vials for COVID-19 Vaccine Sales by Type (2025-2030)
4.1.3 Global Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Vials for COVID-19 Vaccine Revenue by Type (2019-2030)
4.2.1 Global Vials for COVID-19 Vaccine Revenue by Type (2019-2024)
4.2.2 Global Vials for COVID-19 Vaccine Revenue by Type (2025-2030)
4.2.3 Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Vials for COVID-19 Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vials for COVID-19 Vaccine Sales by Application (2019-2030)
5.1.1 Global Vials for COVID-19 Vaccine Sales by Application (2019-2024)
5.1.2 Global Vials for COVID-19 Vaccine Sales by Application (2025-2030)
5.1.3 Global Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Vials for COVID-19 Vaccine Revenue by Application (2019-2030)
5.2.1 Global Vials for COVID-19 Vaccine Revenue by Application (2019-2024)
5.2.2 Global Vials for COVID-19 Vaccine Revenue by Application (2025-2030)
5.2.3 Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Vials for COVID-19 Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Corning
6.1.1 Corning Corporation Information
6.1.2 Corning Description and Business Overview
6.1.3 Corning Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Corning Vials for COVID-19 Vaccine Product Portfolio
6.1.5 Corning Recent Developments/Updates
6.2 Schott AG
6.2.1 Schott AG Corporation Information
6.2.2 Schott AG Description and Business Overview
6.2.3 Schott AG Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Schott AG Vials for COVID-19 Vaccine Product Portfolio
6.2.5 Schott AG Recent Developments/Updates
6.3 SiO2 Materials Science
6.3.1 SiO2 Materials Science Corporation Information
6.3.2 SiO2 Materials Science Description and Business Overview
6.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SiO2 Materials Science Vials for COVID-19 Vaccine Product Portfolio
6.3.5 SiO2 Materials Science Recent Developments/Updates
6.4 SGD Pharma
6.4.1 SGD Pharma Corporation Information
6.4.2 SGD Pharma Description and Business Overview
6.4.3 SGD Pharma Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SGD Pharma Vials for COVID-19 Vaccine Product Portfolio
6.4.5 SGD Pharma Recent Developments/Updates
6.5 Stevanato Group
6.5.1 Stevanato Group Corporation Information
6.5.2 Stevanato Group Description and Business Overview
6.5.3 Stevanato Group Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Stevanato Group Vials for COVID-19 Vaccine Product Portfolio
6.5.5 Stevanato Group Recent Developments/Updates
6.6 DWK Life Sciences
6.6.1 DWK Life Sciences Corporation Information
6.6.2 DWK Life Sciences Description and Business Overview
6.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 DWK Life Sciences Vials for COVID-19 Vaccine Product Portfolio
6.6.5 DWK Life Sciences Recent Developments/Updates
6.7 Gerresheimer
6.6.1 Gerresheimer Corporation Information
6.6.2 Gerresheimer Description and Business Overview
6.6.3 Gerresheimer Vials for COVID-19 Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gerresheimer Vials for COVID-19 Vaccine Product Portfolio
6.7.5 Gerresheimer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vials for COVID-19 Vaccine Industry Chain Analysis
7.2 Vials for COVID-19 Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vials for COVID-19 Vaccine Production Mode & Process
7.4 Vials for COVID-19 Vaccine Sales and Marketing
7.4.1 Vials for COVID-19 Vaccine Sales Channels
7.4.2 Vials for COVID-19 Vaccine Distributors
7.5 Vials for COVID-19 Vaccine Customers
8 Vials for COVID-19 Vaccine Market Dynamics
8.1 Vials for COVID-19 Vaccine Industry Trends
8.2 Vials for COVID-19 Vaccine Market Drivers
8.3 Vials for COVID-19 Vaccine Market Challenges
8.4 Vials for COVID-19 Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Vials for COVID-19 Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Vials for COVID-19 Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Vials for COVID-19 Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Vials for COVID-19 Vaccine Sales (Million Units) of Key Manufacturers (2019-2024)
Table 5. Global Vials for COVID-19 Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Vials for COVID-19 Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Vials for COVID-19 Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Vials for COVID-19 Vaccine Average Price (US$/K Units) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Vials for COVID-19 Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vials for COVID-19 Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vials for COVID-19 Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Vials for COVID-19 Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vials for COVID-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vials for COVID-19 Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vials for COVID-19 Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Vials for COVID-19 Vaccine Sales by Region (2019-2024) & (Million Units)
Table 18. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Vials for COVID-19 Vaccine Sales by Region (2025-2030) & (Million Units)
Table 20. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Vials for COVID-19 Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Vials for COVID-19 Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Vials for COVID-19 Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Vials for COVID-19 Vaccine Sales by Country (2019-2024) & (Million Units)
Table 27. North America Vials for COVID-19 Vaccine Sales by Country (2025-2030) & (Million Units)
Table 28. North America Vials for COVID-19 Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Vials for COVID-19 Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Vials for COVID-19 Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Vials for COVID-19 Vaccine Sales by Country (2019-2024) & (Million Units)
Table 32. Europe Vials for COVID-19 Vaccine Sales by Country (2025-2030) & (Million Units)
Table 33. Europe Vials for COVID-19 Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Vials for COVID-19 Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Vials for COVID-19 Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Vials for COVID-19 Vaccine Sales by Region (2019-2024) & (Million Units)
Table 37. Asia Pacific Vials for COVID-19 Vaccine Sales by Region (2025-2030) & (Million Units)
Table 38. Asia Pacific Vials for COVID-19 Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Vials for COVID-19 Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Vials for COVID-19 Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Vials for COVID-19 Vaccine Sales by Country (2019-2024) & (Million Units)
Table 42. Latin America Vials for COVID-19 Vaccine Sales by Country (2025-2030) & (Million Units)
Table 43. Latin America Vials for COVID-19 Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Vials for COVID-19 Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Vials for COVID-19 Vaccine Sales by Country (2019-2024) & (Million Units)
Table 47. Middle East & Africa Vials for COVID-19 Vaccine Sales by Country (2025-2030) & (Million Units)
Table 48. Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Vials for COVID-19 Vaccine Sales (Million Units) by Type (2019-2024)
Table 51. Global Vials for COVID-19 Vaccine Sales (Million Units) by Type (2025-2030)
Table 52. Global Vials for COVID-19 Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Vials for COVID-19 Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Vials for COVID-19 Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Vials for COVID-19 Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Vials for COVID-19 Vaccine Price (US$/K Units) by Type (2019-2024)
Table 59. Global Vials for COVID-19 Vaccine Price (US$/K Units) by Type (2025-2030)
Table 60. Global Vials for COVID-19 Vaccine Sales (Million Units) by Application (2019-2024)
Table 61. Global Vials for COVID-19 Vaccine Sales (Million Units) by Application (2025-2030)
Table 62. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Vials for COVID-19 Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Vials for COVID-19 Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Vials for COVID-19 Vaccine Price (US$/K Units) by Application (2019-2024)
Table 69. Global Vials for COVID-19 Vaccine Price (US$/K Units) by Application (2025-2030)
Table 70. Corning Corporation Information
Table 71. Corning Description and Business Overview
Table 72. Corning Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 73. Corning Vials for COVID-19 Vaccine Product
Table 74. Corning Recent Developments/Updates
Table 75. Schott AG Corporation Information
Table 76. Schott AG Description and Business Overview
Table 77. Schott AG Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 78. Schott AG Vials for COVID-19 Vaccine Product
Table 79. Schott AG Recent Developments/Updates
Table 80. SiO2 Materials Science Corporation Information
Table 81. SiO2 Materials Science Description and Business Overview
Table 82. SiO2 Materials Science Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 83. SiO2 Materials Science Vials for COVID-19 Vaccine Product
Table 84. SiO2 Materials Science Recent Developments/Updates
Table 85. SGD Pharma Corporation Information
Table 86. SGD Pharma Description and Business Overview
Table 87. SGD Pharma Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 88. SGD Pharma Vials for COVID-19 Vaccine Product
Table 89. SGD Pharma Recent Developments/Updates
Table 90. Stevanato Group Corporation Information
Table 91. Stevanato Group Description and Business Overview
Table 92. Stevanato Group Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 93. Stevanato Group Vials for COVID-19 Vaccine Product
Table 94. Stevanato Group Recent Developments/Updates
Table 95. DWK Life Sciences Corporation Information
Table 96. DWK Life Sciences Description and Business Overview
Table 97. DWK Life Sciences Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 98. DWK Life Sciences Vials for COVID-19 Vaccine Product
Table 99. DWK Life Sciences Recent Developments/Updates
Table 100. Gerresheimer Corporation Information
Table 101. Gerresheimer Description and Business Overview
Table 102. Gerresheimer Vials for COVID-19 Vaccine Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 103. Gerresheimer Vials for COVID-19 Vaccine Product
Table 104. Gerresheimer Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Vials for COVID-19 Vaccine Distributors List
Table 108. Vials for COVID-19 Vaccine Customers List
Table 109. Vials for COVID-19 Vaccine Market Trends
Table 110. Vials for COVID-19 Vaccine Market Drivers
Table 111. Vials for COVID-19 Vaccine Market Challenges
Table 112. Vials for COVID-19 Vaccine Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vials for COVID-19 Vaccine
Figure 2. Global Vials for COVID-19 Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Vials for COVID-19 Vaccine Market Share by Type in 2023 & 2030
Figure 4. Middle-borate Borosilicate Glass Product Picture
Figure 5. Low-borate Borosilicate Glass Product Picture
Figure 6. Global Vials for COVID-19 Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Vials for COVID-19 Vaccine Market Share by Application in 2023 & 2030
Figure 8. Vaccine Manufacturing
Figure 9. Vaccine Researching
Figure 10. Global Vials for COVID-19 Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Vials for COVID-19 Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Vials for COVID-19 Vaccine Sales (2019-2030) & (Million Units)
Figure 13. Global Vials for COVID-19 Vaccine Average Price (US$/K Units) & (2019-2030)
Figure 14. Vials for COVID-19 Vaccine Report Years Considered
Figure 15. Vials for COVID-19 Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Vials for COVID-19 Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Vials for COVID-19 Vaccine Players: Market Share by Revenue in 2023
Figure 18. Vials for COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Vials for COVID-19 Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Vials for COVID-19 Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Vials for COVID-19 Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Vials for COVID-19 Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Vials for COVID-19 Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Vials for COVID-19 Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Vials for COVID-19 Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Vials for COVID-19 Vaccine Sales Market Share by Country (2019-2030)
Figure 43. Latin America Vials for COVID-19 Vaccine Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Vials for COVID-19 Vaccine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Vials for COVID-19 Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Vials for COVID-19 Vaccine by Type (2019-2030)
Figure 53. Global Revenue Market Share of Vials for COVID-19 Vaccine by Type (2019-2030)
Figure 54. Global Vials for COVID-19 Vaccine Price (US$/K Units) by Type (2019-2030)
Figure 55. Global Sales Market Share of Vials for COVID-19 Vaccine by Application (2019-2030)
Figure 56. Global Revenue Market Share of Vials for COVID-19 Vaccine by Application (2019-2030)
Figure 57. Global Vials for COVID-19 Vaccine Price (US$/K Units) by Application (2019-2030)
Figure 58. Vials for COVID-19 Vaccine Value Chain
Figure 59. Vials for COVID-19 Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
